RDY
Price
$14.45
Change
+$0.05 (+0.35%)
Updated
May 16, 04:59 PM (EDT)
Capitalization
12.48B
69 days until earnings call
TLPH
Price
$0.52
Change
+$0.03 (+6.12%)
Updated
May 16, 01:38 PM (EDT)
Capitalization
17.48M
Ad is loading...

RDY vs TLPH

Header iconRDY vs TLPH Comparison
Open Charts RDY vs TLPHBanner chart's image
Dr. Reddy's Laboratories
Price$14.45
Change+$0.05 (+0.35%)
Volume$9.32K
Capitalization12.48B
Talphera
Price$0.52
Change+$0.03 (+6.12%)
Volume$1.12K
Capitalization17.48M
RDY vs TLPH Comparison Chart
Loading...
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RDY vs. TLPH commentary
May 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDY is a Hold and TLPH is a Hold.

Ad is loading...
COMPARISON
Comparison
May 16, 2025
Stock price -- (RDY: $14.39 vs. TLPH: $0.49)
Brand notoriety: RDY and TLPH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RDY: 50% vs. TLPH: 111%
Market capitalization -- RDY: $12.48B vs. TLPH: $17.48M
RDY [@Pharmaceuticals: Other] is valued at $12.48B. TLPH’s [@Pharmaceuticals: Other] market capitalization is $17.48M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RDY’s FA Score shows that 1 FA rating(s) are green whileTLPH’s FA Score has 0 green FA rating(s).

  • RDY’s FA Score: 1 green, 4 red.
  • TLPH’s FA Score: 0 green, 5 red.
According to our system of comparison, RDY is a better buy in the long-term than TLPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RDY’s TA Score shows that 7 TA indicator(s) are bullish while TLPH’s TA Score has 2 bullish TA indicator(s).

  • RDY’s TA Score: 7 bullish, 2 bearish.
  • TLPH’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, RDY is a better buy in the short-term than TLPH.

Price Growth

RDY (@Pharmaceuticals: Other) experienced а +9.18% price change this week, while TLPH (@Pharmaceuticals: Other) price change was -11.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.72%. For the same industry, the average monthly price growth was +12.60%, and the average quarterly price growth was +27.89%.

Reported Earning Dates

RDY is expected to report earnings on Jul 24, 2025.

TLPH is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.72% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDY($12.5B) has a higher market cap than TLPH($17.5M). TLPH YTD gains are higher at: -6.506 vs. RDY (-8.866). RDY has higher annual earnings (EBITDA): 84.9B vs. TLPH (-9.84M). RDY has more cash in the bank: 72.4B vs. TLPH (9.38M). RDY has higher revenues than TLPH: RDY (271B) vs TLPH (651K).
RDYTLPHRDY / TLPH
Capitalization12.5B17.5M71,429%
EBITDA84.9B-9.84M-862,630%
Gain YTD-8.866-6.506136%
P/E Ratio19.68N/A-
Revenue271B651K41,628,264%
Total Cash72.4B9.38M771,773%
Total Debt19.9BN/A-
FUNDAMENTALS RATINGS
RDY vs TLPH: Fundamental Ratings
RDY
TLPH
OUTLOOK RATING
1..100
2659
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
33100
SMR RATING
1..100
4898
PRICE GROWTH RATING
1..100
5183
P/E GROWTH RATING
1..100
45100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TLPH's Valuation (72) in the Pharmaceuticals Other industry is in the same range as RDY (79) in the Pharmaceuticals Generic industry. This means that TLPH’s stock grew similarly to RDY’s over the last 12 months.

RDY's Profit vs Risk Rating (33) in the Pharmaceuticals Generic industry is significantly better than the same rating for TLPH (100) in the Pharmaceuticals Other industry. This means that RDY’s stock grew significantly faster than TLPH’s over the last 12 months.

RDY's SMR Rating (48) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TLPH (98) in the Pharmaceuticals Other industry. This means that RDY’s stock grew somewhat faster than TLPH’s over the last 12 months.

RDY's Price Growth Rating (51) in the Pharmaceuticals Generic industry is in the same range as TLPH (83) in the Pharmaceuticals Other industry. This means that RDY’s stock grew similarly to TLPH’s over the last 12 months.

RDY's P/E Growth Rating (45) in the Pharmaceuticals Generic industry is somewhat better than the same rating for TLPH (100) in the Pharmaceuticals Other industry. This means that RDY’s stock grew somewhat faster than TLPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RDYTLPH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
45%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 11 days ago
50%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
45%
N/A
View a ticker or compare two or three
Ad is loading...
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

RDY and

Correlation & Price change

A.I.dvisor tells us that RDY and KMDA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+1.77%
KMDA - RDY
26%
Poorly correlated
-2.70%
COLL - RDY
26%
Poorly correlated
+0.93%
AVDL - RDY
26%
Poorly correlated
+4.22%
TAK - RDY
25%
Poorly correlated
+2.12%
VTRS - RDY
23%
Poorly correlated
+4.39%
More

TLPH and

Correlation & Price change

A.I.dvisor tells us that TLPH and LVZPF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and LVZPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPH
1D Price
Change %
TLPH100%
-3.92%
LVZPF - TLPH
31%
Poorly correlated
N/A
TXMD - TLPH
24%
Poorly correlated
N/A
RDY - TLPH
22%
Poorly correlated
+1.77%
OILFF - TLPH
20%
Poorly correlated
+13.87%
LFCR - TLPH
19%
Poorly correlated
+0.60%
More